Opportunity Information: Apply for PAR 17 108
The grant opportunity titled "Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44)" is a National Institutes of Health (NIH) Small Business Innovation Research (SBIR) funding announcement aimed at pushing practical, market-relevant robotics innovations into dementia care. The central focus is on developing socially-assistive robots and related technologies that can meaningfully support older adults living with Alzheimer's disease, AD-related dementias, and other common coexisting health conditions. The intent is not just to create impressive prototypes, but to encourage solutions that can enhance health, reduce illness, and limit disability by improving day-to-day functioning, engagement, and overall well-being for people affected by cognitive decline.
A key feature of this opportunity is its dual emphasis: it supports technologies designed for individuals with AD/ADRD and it also explicitly encourages tools that address the needs of caregivers. That caregiver angle matters because dementia care often places heavy physical, emotional, and logistical demands on family members and professional caregivers. In practice, this means proposed robotics solutions could be aimed at helping caregivers manage routines, reduce supervision burden, support safe independence for the person with dementia, ease stress, and improve the quality of interactions between caregiver and care recipient. The "socially-assistive" aspect signals an interest in robots that go beyond physical assistance (like lifting or mobility) and instead use social interaction, prompts, coaching, companionship-like engagement, or behavior-shaping strategies to support health and functioning.
From an administrative standpoint, this is a discretionary grant program using the SBIR mechanism under the R43/R44 phases, which generally correspond to early-stage feasibility development (Phase I) and more advanced research and development leading toward commercialization (Phase II). The eligible applicants are small businesses, aligning with SBIR's goal of translating research into products and services with real-world uptake. The opportunity is listed under the health funding activity category and tied to CFDA number 93.866, which is associated with NIH Alzheimer's and related research activities.
Eligibility rules are straightforward and restrictive in terms of foreign participation. Non-U.S. entities (foreign institutions) are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible to submit as applicants. However, "foreign components" as defined by the NIH Grants Policy Statement may be allowed in some cases, which typically refers to specific parts of the work being performed outside the United States under defined conditions and NIH approval, rather than a foreign organization serving as the primary applicant.
The source details indicate the funding opportunity number is PAR 17-108, it was created on January 9, 2017, and the original closing date listed is July 5, 2020. The record does not specify an award ceiling or the expected number of awards in the provided excerpt, so applicants would typically need to consult the full NIH announcement for budget caps, project period limits, review criteria, and any special requirements tied to clinical testing, human subjects, or commercialization planning.
Overall, the opportunity is aimed at motivating small businesses to build and validate assistive and socially interactive robotic systems that can be realistically used in dementia care settings, improving outcomes for people living with AD/ADRD while also reducing the strain and challenges faced by those who care for them.Apply for PAR 17 108
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.866.
- This funding opportunity was created on 2017-01-09.
- Applicants must submit their applications by 2020-07-05. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R43/R44)."
Which agency is offering this funding opportunity?
This is a National Institutes of Health (NIH) funding announcement.
What type of program is this (grant mechanism)?
It is a Small Business Innovation Research (SBIR) opportunity using the R43/R44 mechanisms, which align with Phase I (early-stage feasibility development) and Phase II (more advanced R&D leading toward commercialization).
What is the main purpose of the opportunity?
The purpose is to push practical, market-relevant robotics innovations into dementia care by supporting the development of socially-assistive robots (SARs) and related technologies that can meaningfully support older adults living with AD/ADRD and common coexisting health conditions.
What does "socially-assistive robots (SARs)" mean in this context?
In this announcement, "socially-assistive" emphasizes robots that support people through social interaction (such as prompts, coaching, engagement, companionship-like interaction, or behavior-shaping strategies) rather than focusing only on physical assistance like lifting or mobility.
Who is the technology intended to help?
The technology is intended to support people living with Alzheimer's disease (AD), AD-related dementias (ADRD), and other common coexisting health conditions, with an explicit emphasis on dementia care contexts.
Does this opportunity also support tools for caregivers?
Yes. A key feature is its dual emphasis: it supports technologies for individuals with AD/ADRD and explicitly encourages tools that address caregiver needs.
What kinds of caregiver needs are highlighted in the description?
The description highlights solutions that could help caregivers manage routines, reduce supervision burden, support safe independence for the person with dementia, ease stress, and improve the quality of interactions between caregiver and care recipient.
Is the goal to build prototypes, or to develop real-world products?
The intent is not just to create impressive prototypes. The opportunity emphasizes practical solutions that can be realistically used in dementia care settings and that are market-relevant, aligning with SBIR's commercialization focus.
What outcomes is NIH trying to improve through this funding?
The announcement emphasizes enhancing health, reducing illness, and limiting disability by improving day-to-day functioning, engagement, and overall well-being for people affected by cognitive decline.
Who is eligible to apply?
Eligible applicants are small businesses, consistent with the SBIR program's purpose of translating research into products and services with real-world uptake.
Are foreign organizations eligible to apply?
No. Non-U.S. entities (foreign institutions) are not eligible to apply.
Can a non-U.S. component of a U.S. organization apply?
No. Non-U.S. components of U.S. organizations are not eligible to submit as applicants.
Are any foreign activities allowed at all?
Potentially. The description notes that "foreign components" (as defined by the NIH Grants Policy Statement) may be allowed in some cases. This generally refers to specific parts of work being performed outside the U.S. under defined conditions and with NIH approval, rather than a foreign organization serving as the primary applicant.
What is the funding opportunity number?
The funding opportunity number is PAR 17-108.
When was this opportunity created?
The record states it was created on January 9, 2017.
What is the closing date listed in the provided information?
The original closing date listed is July 5, 2020.
Is this a discretionary grant program?
Yes. The description identifies it as a discretionary grant program using the SBIR mechanism.
What is the activity category associated with this opportunity?
It is listed under the health funding activity category.
What CFDA number is associated with this opportunity?
The opportunity is tied to CFDA number 93.866, which is associated with NIH Alzheimer's and related research activities.
Does the provided information state the award ceiling or number of awards?
No. The excerpt does not specify an award ceiling or the expected number of awards.
Does the provided information include budget caps, project period limits, or review criteria?
No. The excerpt notes that applicants would typically need to consult the full NIH announcement for details such as budget caps, project period limits, review criteria, and any special requirements.
Does the provided information mention clinical testing or human subjects requirements?
The excerpt does not provide those specifics. It only notes that special requirements related to clinical testing, human subjects, or commercialization planning may exist in the full NIH announcement.
Browse more opportunities from the same category: Health
Next opportunity: Rural Health and Safety Education Competitive Grants Program
Previous opportunity: Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 17 108
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 17 108) also looked into and applied for these:
| Funding Opportunity |
|---|
| Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01) Apply for PA 17 106 Funding Number: PA 17 106 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21) Apply for PA 17 105 Funding Number: PA 17 105 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NINDS Exploratory Clinical Trials (R01) Apply for PAR 17 122 Funding Number: PAR 17 122 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Project Manager for Kenya PEPFAR Sites Analysis Apply for SBUR SOGAC 16 003 Funding Number: SBUR SOGAC 16 003 Agency: Office of the Secretary Category: Health Funding Amount: $3,100,000 |
| Expanding and Strengthening Family Planning Service Options in Uganda Apply for RFA 617 17 000002 Funding Number: RFA 617 17 000002 Agency: Uganda USAID-Kampala Category: Health Funding Amount: $35,000,000 |
| Sex Hormone Induced Thromboembolism in Pre-Menopausal Women (R61/R33) Apply for RFA HL 18 003 Funding Number: RFA HL 18 003 Agency: National Institutes of Health Category: Health Funding Amount: $475,000 |
| Juvenile Protective Factors and Their Effects on Aging (R01) Apply for PAR 17 126 Funding Number: PAR 17 126 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Juvenile Protective Factors and Their Effects on Aging (R03) Apply for PAR 17 127 Funding Number: PAR 17 127 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Research Program Award (R35) Apply for RFA NS 17 020 Funding Number: RFA NS 17 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Demographic Surveillance System Support in the Republic of Mozambique under the President's Emergency Apply for CDC RFA GH17 1725 Funding Number: CDC RFA GH17 1725 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: $800,000 |
| Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R03) Apply for PA 17 134 Funding Number: PA 17 134 Agency: National Institutes of Health Category: Health Funding Amount: $50,000 |
| Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R21) Apply for PA 17 132 Funding Number: PA 17 132 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Public Policy Effects on Alcohol-, Marijuana-, and Other Substance-Related Behaviors and Outcomes (R01) Apply for PA 17 135 Funding Number: PA 17 135 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Stimulating Peripheral Activity to Relieve Conditions (SPARC): Foundational Peripheral Neuroanatomy and Functional Neurobiology in Under-Studied Organs (U01) Apply for RFA RM 17 003 Funding Number: RFA RM 17 003 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Improving Outcomes for Disorders of Human Communication (R01) Apply for PA 17 139 Funding Number: PA 17 139 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Outcomes for Disorders of Human Communication (R21) Apply for PA 17 140 Funding Number: PA 17 140 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| International Research in Infectious Diseases, including AIDS (R01) Apply for PAR 17 142 Funding Number: PAR 17 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: National Primate Research Centers (P51) Apply for PAR 17 144 Funding Number: PAR 17 144 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Postdoctoral Mentored Career Development Award (K01) Apply for PAR 17 145 Funding Number: PAR 17 145 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| International Research in Infectious Diseases, including AIDS (R01) Apply for PA 17 142 Funding Number: PA 17 142 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 17 108", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.